🔎 Trials Near Me

Gara Jalqabaatti › Dukkana Dhiigaa › Tennessee › Nashville

Qorannoo klinikaalii Dukkana Dhiigaa Nashville, TN keessatti

Qorannoo 13 Dukkana Dhiigaa f Nashville fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Namoota walitti qabaa jiraSadarkaa 3
  • Vanderbilt Health One Hundred Oaks Diagnostic ( Site 0060), Nashville
  • Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 0015), Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT03486873

A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Sarah Cannon Cancer Institute, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07572006

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Namoota walitti qabaa jiraSadarkaa 3
  • Quetzal Site 12, Nashville
Umuriin 18 hanga 71 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07504458

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Scri Oncology Partners, Nashville
  • Vanderbilt Medical Center, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07195916

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Namoota walitti qabaa jiraSadarkaa 3
  • Tennessee Oncology, Nashville
  • TriStar Centennial Medical Center, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Vanderbilt University Medical Center, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT06001788

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

Namoota walitti qabaa jiraSadarkaa 1
  • Sarah Cannon Research Institute - Oncology Partners, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT06823167

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Namoota walitti qabaa jiraSadarkaa 2
  • Vanderbilt University, Ingram Cancer Center, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Vanderbilt University, Nashville
Umuriin hundi · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT01351545

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

Namoota walitti qabaa jiraSadarkaa 3
  • The Children's Hospital at TriStar Centennial, Nashville
  • Vanderbilt University/Ingram Cancer Center, Nashville
Umuriin 2 hanga 18 · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT05711667

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Namoota walitti qabaa jiraSadarkaa 1
  • TriStar Bone Marrow Transplant, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT05735184

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

Namoota walitti qabaa jiraSadarkaa 1/2
  • SCRI Oncology Partners, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Wax-2025 · NCT06119685

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • TriStar Bone Marrow Transplant, Nashville
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Sad-2024 · NCT06034275

Qorannoo Dukkana Dhiigaa magaalota biroo keessatti

Qorannoo biroo Nashville keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.